GRAHAM RICHARD A 4
4 · Theravance Biopharma, Inc. · Filed Jun 16, 2023
Insider Transaction Report
Form 4
GRAHAM RICHARD A
SVP, Development
Transactions
- Sale
Ordinary Shares
2023-06-14$10.69/sh−2,322$24,822→ 354,390 total
Footnotes (1)
- [F1]This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.